External electrical cardioversion of atrial arrhythmias: Predictors of a successful procedure;Cardioversion électrique externe des troubles du rythme atriaux: Critères prédictifs de succès

Annales de Cardiologie et d'Angeiologie

Volumn 52, Issue 4, 2003, Pages 232-238

  Paziaud, O ^a   Piot, O ^b   Rousseau, J ^b   Copie, X ^b   Lavergne, T ^a   Guize, L ^a   Le Heuzey, J Y ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b CENTRE CARDIOLOGIQUE DU NORD   (France)

Author keywords

Atrial fibrillation; Atrial flutter; Electrical cardioversion; Spironolactone

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDROPYRIDINE; FUROSEMIDE; SOTALOL; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVERSION; DIRECT CURRENT; DIRECT CURRENT CARDIOVERSION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; SINUS RHYTHM;

EID: 0141682547     PISSN: 00033928     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-3928(03)00089-1     Document Type: Article

References (31)

1. Kulbertus H, Leval-Rutten FD, Bartsch P. Atrial fibrillation in elderly ambulatory patients. In: Kulbertus H, Olsson S, Schlepper M, editors. Atrial fibrillation. Môlndal: AB Hassle; 1982. p. 102.
2. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-22.
3. Martin A, Benbow LJ, Butrous GS, Leach C, Camm AJ. Five-years follow-up of 101 elderly subjects by means of long-term ambulatory cardiac monitoring. Eur Heart J 1984;5:592-6.
4. Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS. Prevalence and significance of atrial fibrillation in coronary artery disease (CASS Registry). Am J Cardiol 1988;61:714-7.
5. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients, Circulation 1991;84:40-8.
6. Brembilla-Perrot B. Indications de la régularisation d'une fibrillation auriculaire en 2001. Ann Cardiol Angeiol 2001;50(6):326-9.
7. Dalzell GW, Anderson J, Adgey AA. Factors determining success and energy requirements for cardioversion of atrial fibrillation: revised version. Q J Med 1991;78:85-95.
8. Levy S, Lauribe P, Dolla E, Kou W, Kadish A, Calkins H, et al. A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992;86:1415-20.
9. Morris J, Peter R, McIntosh H. Electrical cardioversion of atrial fibrillation: immediate and long term results and selection of patients. Ann Intern Med 1966;65:216-31.
10. Bjerkelund C, Orning OM. An evaluation of DC shock treatment of atrial arrhythmias. Acta Med Scand 1968;184:481-91.
11. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-6.
12. Levy S, Breithardt G, Campbell RW, Camm AJ, Daubert JC, Allessie M, et al. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J 1998;19:1294-320.
13. Lerman BB, Deale OC. Relation between transcardiac and transthoracic current during defibrillation in humans. Circ Res 1990;67:1420-6.
14. Kerber RE, Grayzel J, Hoyt R, Marcus M, Kennedy J. Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure. Circulation 1981;63:676-82.
15. Waktare JE, Camm AJ. Acute treatment of atrial fibrillation: why and when to maintain sinus rhythm? Am J Cardiol 1998;81:3C-15C.
16. Naccarelli GV, Dell'Orfano JT, Wolbrette DL, Patel HM, Luck JC. Cost-effective management of acute atrial fibrillation: role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. Am J Cardiol 2000;85:36D-45D.
17. Akyurek O, Ertas FS, Diker E, Karaoguz R, Guldal M, Oral D. Role of atrial pressure in the success of electrical cardioversion of chronic atrial fibrillation. Am J Cardiol 2000;86:223-6.
18. Piot O, Paziaud O, Digeos S, Copie X, Lavergne T, Guize L, et al. Remodelage électrophysiologique induit par la fibrillation atriale. Curiosité expérimentale ou déterminant majeur de la fibrillation atriale chez l'homme? Arch Mal Cüur 2000;93(84):1-8.
19. Allessie MA. Atrial electrophysiologic remodeling: another vicious circle? J Cardiovasc Electrophysiol 1998;9:1378-93.
20. Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, Tieleman RG, Crijns HJ. Pharmacologic vs direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 1999;84:147R-51R.
21. Klein AL, Grimm RA, Murray RD, Apperson-Hasen C, Hasiger RW, Black IW, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411-20.
22. Henry WL, Morganroth J, Pearlman AS, Clark CE, Redwood DR, Itscoitz SB, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53:273-9.
23. Brodsky MA, Allen BJ, Capparelli EV, Luckett CR, Morton R, Henry WL. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989;63:1065-8.
24. Dittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989;63:193-7.
25. Ewy GA, Ulfers L, Hager WD, Rosenfeld AR, Roeske WR, Goldman S. Response of atrial fibrillation to therapy: role of etiology and left atrial diameter. J Electrocardiol 1980;13:119-23.
26. Opolski G, Stanislawska J, Gorecki A, Swiecicka G, Torbicki A, Kraska T. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clin Cardiol 1997;20:337-40.
27. Goette A, Hoffmanns P, Enayati W, Meltendorf U, Geller JC, Klein HU. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. Am J Cardiol 2001;88:906-9 A8.
28. 4 alone and in combination with glucose, insulin and potassium (GIK) prolong the atrial cycle length in chronic atrial fibrillation. Europace 2000;2:106-14.
29. Bode F, Katchman A, Woosley RL, Franz MR. Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation 2000;101:2200-5.
30. Schohn DC, Jahn HA, Pelletier BC. Dose-related cardiovascular effects of spironolactone. Am J Cardiol 1993;71:40A-5A.
31. Zannad F, Alla F, Dousset B, Perez A, Pitt B. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (Rales). Rales Investigators. Circulation 2000;102:2700-6.